Dawson James Stock Recommendations and Price Targets

This is a list of recent ratings by Dawson James.

DateCompany NameActionCurrent
Price
Price
Target
Rating
2/28/2024
TNXP
Tonix Pharmaceuticals
Initiated Coverage$20.00 $9,600.00Buy
1/30/2024
DARE
Dare Bioscience
Downgrade$2.00Buy ➝ Neutral
9/27/2023
BYRN
Byrna Technologies
Downgrade$19.00Buy ➝ Neutral
8/15/2023
XXII
22nd Century Group
Lower Price Target$1.00$496,800.00 ➝ $372,600.00Buy ➝ Buy
8/3/2023
BJDX
Bluejay Diagnostics
Downgrade$1.00Buy ➝ Neutral
7/25/2023
XXII
22nd Century Group
Lower Price Target$1.00$745,200.00 ➝ $496,800.00
7/17/2023
THAR
Tharimmune
Downgrade$2.00Buy ➝ Neutral
7/12/2023
BYRN
Byrna Technologies
Lower Price Target$19.00$9.50 ➝ $7.25
7/11/2023
TOON
Kartoon Studios
Lower Price Target$1.00$12.50 ➝ $10.00
7/3/2023
XXII
22nd Century Group
Lower Price Target$1.00$3,353,400.00 ➝ $745,200.00
3/17/2023
NRXP
NRx Pharmaceuticals
Reiterated Rating$2.00Buy
3/3/2023
GOVX
GeoVax Labs
Initiated Coverage$0.00 $60.00Buy
2/28/2023
SMSI
Smith Micro Software
Lower Price Target$1.00$66.40 ➝ $28.00
2/22/2023
THAR
Tharimmune
Reiterated Rating$2.00Buy
2/13/2023
SRNE
Sorrento Therapeutics
Downgrade$0.00Buy ➝ Neutral
2/6/2023
CETX
Cemtrex
Boost Price Target$3.00$4,200.00 ➝ $12,075.00Buy
1/30/2023
GNPX
Genprex
Initiated Coverage$3.00 $6,000.00Buy
1/3/2023
CANF
Can-Fite BioPharma
Downgrade$0.00Buy ➝ Neutral